Home > National Drug Code (NDC) > Irbesartan and Hydrochlorothiazide

Irbesartan and Hydrochlorothiazide - 60505-3605-3 - (Irbesartan and Hydrochlorothiazide)

Alphabetical Index


Drug Information of Irbesartan and Hydrochlorothiazide

Product NDC: 60505-3605
Proprietary Name: Irbesartan and Hydrochlorothiazide
Non Proprietary Name: Irbesartan and Hydrochlorothiazide
Active Ingredient(s): 25; 300    mg/1; mg/1 & nbsp;   Irbesartan and Hydrochlorothiazide
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of Irbesartan and Hydrochlorothiazide

Product NDC: 60505-3605
Labeler Name: Apotex Corp.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA201505
Marketing Category: ANDA
Start Marketing Date: 20120926

Package Information of Irbesartan and Hydrochlorothiazide

Package NDC: 60505-3605-3
Package Description: 30 TABLET, FILM COATED in 1 BOTTLE (60505-3605-3)

NDC Information of Irbesartan and Hydrochlorothiazide

NDC Code 60505-3605-3
Proprietary Name Irbesartan and Hydrochlorothiazide
Package Description 30 TABLET, FILM COATED in 1 BOTTLE (60505-3605-3)
Product NDC 60505-3605
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Irbesartan and Hydrochlorothiazide
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20120926
Marketing Category Name ANDA
Labeler Name Apotex Corp.
Substance Name HYDROCHLOROTHIAZIDE; IRBESARTAN
Strength Number 25; 300
Strength Unit mg/1; mg/1
Pharmaceutical Classes Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient]

Complete Information of Irbesartan and Hydrochlorothiazide


General Information